{
    "organizations": [],
    "uuid": "9bb5190d0dc3856d1db60305f6908e2be1fba1bf",
    "author": "",
    "url": "https://www.reuters.com/article/brief-vascepa-showed-fall-in-atherogenic/brief-vascepa-showed-fall-in-atherogenic-lipid-inflammatory-markers-in-statin-treated-patients-with-reduced-kidney-function-idUSFWN1RP06V",
    "ord_in_thread": 0,
    "title": "BRIEF-Vascepa Showed Fall In Atherogenic Lipid, Inflammatory Markers In Statin Treated Patients With Reduced Kidney Function",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 12 (Reuters) - Amarin Corporation PLC:\n* VASCEPA SHOWED FALL IN ATHEROGENIC LIPID, INFLAMMATORY MARKERS IN STATIN-TREATED PATIENTS WITH REDUCED KIDNEY FUNCTION, PERSISTENT HIGH TRIGLYCERIDES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-12T12:10:00.000+03:00",
    "crawled": "2018-04-12T12:31:07.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "amarin",
        "corporation",
        "plc",
        "vascepa",
        "showed",
        "fall",
        "atherogenic",
        "lipid",
        "inflammatory",
        "marker",
        "patient",
        "reduced",
        "kidney",
        "function",
        "persistent",
        "high",
        "triglyceride",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}